CTAS
40
-2
SHW
43
-10
PNW
53
-3
INTC
43
6
MHK
43
-2
FLS
61
13
PBI
68
2
HIG
68
5
MRK
63
3
HCA
64
5
PM
49
2
VFC
70
2
GOOGL
47
4
AVGO
54
12
LOW
43
-6
SO
46
-5
HBAN
82
3
HRB
46
4
CCL
81
16
PSX
37
2
CTAS
40
-2
SHW
43
-10
PNW
53
-3
INTC
43
6
MHK
43
-2
FLS
61
13
PBI
68
2
HIG
68
5
MRK
63
3
HCA
64
5
PM
49
2
VFC
70
2
GOOGL
47
4
AVGO
54
12
LOW
43
-6
SO
46
-5
HBAN
82
3
HRB
46
4
CCL
81
16
PSX
37
2
Financhill
Back

Nautilus Biotechnology, Inc. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Sell
34

NAUT
Nautilus Biotechnology, Inc.

Last Price:
$1.98
Seasonality Move:
-17.65%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$59.30
Seasonality Move:
5.52%
Sell
34
Nautilus Biotechnology, Inc. (NAUT) is a Sell

Is Nautilus Biotechnology, Inc. a Buy, Sell or Hold?

  • The current Nautilus Biotechnology, Inc. [NAUT] share price is $1.94. The Score for NAUT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NAUT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NAUT Stock Price Chart

What is Nautilus Biotechnology, Inc.'s stock price today?

  • The Nautilus Biotechnology, Inc. share price today is $1.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAUT is experiencing slight buying pressure.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

NAUT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 52.01 Buy
Chaikin Money Flow: 83061 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.89 - 2.19) Sell
Bollinger Bands (100): (0.66 - 1.78) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

NAUT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Buy
20-day SMA: 2.03 Sell
50-day SMA: 1.7 Buy
200-day SMA: 1.01 Buy
8-day EMA: 1.93 Buy
20-day EMA: 1.94 Buy
50-day EMA: 1.64 Buy
200-day EMA: 0.72 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Nautilus Biotechnology, Inc. Earnings Growth & NAUT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.03 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.73 per share.

Nautilus Biotechnology, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):